Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Research Associate

Analytical Chemistry · Sri Lanka · 2025-01-16

Processing Time
334 days
Decision Date
2025-01-16
Location
Illinois
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to examine cellular lipid and protein abnormalities associated with neurological disorders to pinpoint drug targets and develop effective therapies. The work focuses on identifying biomarkers for the diagnosis of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Niemann-Pick. This research aims to improve patient outcomes and quality of life for those suffering from fatal medical conditions.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses pressing medical challenges in understanding and combating neurodegenerative diseases like Alzheimer's.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., publication record, and support from major funding organizations like the NIH demonstrate readiness to lead the research.

3 Waiver Benefit Met

The groundbreaking nature of the research and its potential to drive new diagnostic tools make it beneficial to waive the labor certification.

Why This Petition Was Approved

The petition was approved based on the client's Ph.D. in chemistry and a portfolio of 7 peer-reviewed journal publications, 11 conference abstracts, and 2 book chapters. The evidence included 63 citations and the completion of at least 6 peer reviews for reputable journals. The case satisfied all three Dhanasar prongs, supported by four expert recommendation letters and funding from major agencies like the NIH.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Judging Experience
Reference Letters Dependent
Grants
Original Contributions

Similar Cases

Doctor

Biotechnology · China

WeGreened EB-2 (NIW) rfe approved
484 days 2025-10-31
The petitioner proposes to continue critical research using cellular and molecular techniques to elucidate the mechanisms of neurodegenerative diseases. This work aims to facilitate the development of new and improved prognostic and diagnostic tools for medical applications.
View Case

Data Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
603 days 2025-09-20
The petitioner proposes to develop computational and analytical tools to characterize the mechanisms of chronic and complex diseases. This work involves integrating large-scale biological data to accelerate the discovery of treatment strategies for neurodegenerative disorders and metabolic diseases.
View Case

Scientist

Research and Development · India

WeGreened EB-2 (NIW) approved
Alabama 6 days 2024-03-07
The petitioner proposes to continue research using mouse model systems, high-resolution imaging, and molecular biology techniques to discover the mechanisms and molecular pathology of Parkinson’s disease. The work focuses on identifying effective therapeutic targets to improve patient quality of life and alleviate the economic burden associated with the condition.
View Case

Postdoctoral Researcher

Biotechnology · Turkey

WeGreened EB-2 (NIW) approved
Michigan 568 days 2025-11-19
The petitioner proposes to discover new biomarkers for cancer, neurodegenerative diseases, metabolic disorders, and inflammatory conditions by analyzing molecular irregularities in biological samples. This work involves developing refined methods for identifying disease-associated molecular signatures to enable earlier detection and innovative therapeutic strategies, such as hormone-based and immune-based treatments.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Sri Lanka

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-01-16.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 334 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Sri Lanka All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist